Compounds > canrenone
Page last updated: 2024-08-21

canrenone and amiloride

canrenone has been researched along with amiloride in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Juhos, E; Radó, JP; Sawinsky, I2
Käsmayr, J; Theisen, K; Wehling, M1
Haddy, FJ; Pamnani, MB1
Caligiuri, A; De Franco, RM; Failli, P; Geerts, A; Gentilini, A; Gentilini, P; Marra, F; Mazzetti, L; Meucci, M; Pinzani, M; Romanelli, RG; Rombouts, K; Vanasia, M1
Armanini, D; Calò, LA; Fiore, C; Pagnin, E; Ragazzi, E; Sartorato, P1

Reviews

1 review(s) available for canrenone and amiloride

ArticleYear
Pharmacologic agents for the in vivo detection of vascular sodium transport defects in hypertension.
    Life sciences, 1987, Dec-21, Volume: 41, Issue:25

    Topics: Amiloride; Animals; Biological Transport, Active; Canrenone; Humans; Hypertension; Ion Channels; Ouabain; Sodium; Sodium-Potassium-Exchanging ATPase; Vascular Diseases

1987

Other Studies

5 other study(ies) available for canrenone and amiloride

ArticleYear
Paradoxical reversal of the suppressed potassium secretion during treatment with combinations of antikaluretic agents (spironolactone, canrenone, triamterene, amiloride); a possible site of action in Henle's loop.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1976, Volume: 8, Issue:3

    Topics: Amiloride; Canrenone; Humans; Kidney Tubules; Liver Cirrhosis; Loop of Henle; Male; Middle Aged; Potassium; Pregnadienes; Pyrazines; Sodium; Spironolactone; Triamterene

1976
Reversal of the suppressed potassium excretion during treatment with combinations of antikaliuretic drugs (spironolactone, canrenone, triamterene, amiloride) in patients with liver cirrhosis.
    International journal of clinical pharmacology and biopharmacy, 1976, Volume: 14, Issue:3

    Topics: Amiloride; Ascites; Canrenone; Diuresis; Diuretics; Drug Synergism; Drug Therapy, Combination; Humans; Liver Cirrhosis; Natriuresis; Potassium; Spironolactone; Triamterene

1976
Aldosterone influences free intracellular calcium in human mononuclear leukocytes in vitro.
    Cell calcium, 1990, Volume: 11, Issue:9

    Topics: Adolescent; Adult; Aged; Aldosterone; Amiloride; Calcium; Canrenoic Acid; Canrenone; Corticosterone; Cycloheximide; Dactinomycin; Humans; Hydrocortisone; Leukocytes, Mononuclear; Middle Aged

1990
Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells.
    Gastroenterology, 2003, Volume: 124, Issue:2

    Topics: Aldosterone; Amiloride; Calcium; Canrenone; Cell Division; Cell Movement; Cells, Cultured; Extracellular Matrix Proteins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Guanidines; Humans; Hydrogen-Ion Concentration; Intracellular Membranes; Liver; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Phosphatidylinositol 3-Kinases; Phosphorylation; Platelet-Derived Growth Factor; Protein-Tyrosine Kinases; Signal Transduction; Sodium-Hydrogen Exchangers; Sulfones; Thrombin

2003
Effect of canrenone and amiloride on the prooxidative effect induced by aldosterone in human mononuclear leukocytes in vitro.
    Journal of endocrinological investigation, 2009, Volume: 32, Issue:11

    Topics: Adult; Aldosterone; Amiloride; Canrenone; Female; Humans; Hydrocortisone; Leukocytes, Mononuclear; Male; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Sodium Channel Blockers

2009